Home > Analytics > AJANTA PHARMA

AJANTA PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 532331     NSE : AJANTPHARM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Aug 18,2022
Price(EOD): ₹ 1,258.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 16,123.31 Cr
Value of ₹ 1 Lac invested in AJANTA PHARMA
on Aug 18,2017 (price: ₹ 804.10)

₹ 1 L

₹ 1.57 L

1W : -1% 1M : 1.9% 1Y : -14.9%
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
Industry Peers & Returns1W1M1Y
AJANTA PHARMA -1% 1.9% -14.9%
SUN PHARMACEUTICAL INDUSTRIES -0.5% 3.7% 18.3%
DIVIS LABORATORIES -5.2% 0.2% -23.8%
DR REDDYS LABORATORIES -0.7% -5.4% -9%
CIPLA -0.6% 6.8% 14.7%
GLAND PHARMA 2.2% -2.6% -44.7%
PIRAMAL ENTERPRISES 2.9% 15.5% -27.5%
CADILA HEALTHCARE 3.2% 10% -28.4%
TORRENT PHARMACEUTICALS 1.6% 3.6% 5.1%

FUNDAMENTAL ANALYSIS OF AJANTA PHARMA

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 AJANTPHARM is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF AJANTA PHARMA

 
Valuation Score
[As on : Aug 18,2022 ]

Ratio Consolidated
P/E
P/B
P/S
15.08
P/E Calculated based on EPS of 83.45
[ Mar2022 - Consolidated Results ]

3.29
P/B Calculated based on Book Value of 382.2
[ Mar2022 - Consolidated Results ]

4.55
P/S Calculated based on Revenues of 3543.93 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF AJANTA PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
62%
88%
100%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AJANTA PHARMA


Insights 💡 AJANTPHARM is one of the top 51% companies with bullish price momentum currently! Discover More →

AJANTA PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AJANTA PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0
-
0
0
0.02
0.01
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AJANTA PHARMA

Pledged Promoter Shares
20.09 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AJANTA PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
9.27%
7.29%
12.24%
15.48%
27.13%
0.7%
0.64%
0.5%
QtrlyTrend
8
Latest Qtr: Jun2022
Quarterly Result Analysis →


AJANTA PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE 150 MIDCAP 3.2% 11.9% 11.7%
S&P BSE 400 MIDSMALLCAP 2.8% 11.3% 9.8%
S&P BSE 250 LARGEMIDCAP 2.7% 12.5% 11.4%
S&P BSE LARGE MIDCAP 2.7% 12.5% 11.3%
S&P BSE 500 2.7% 12.3% 11%
NSE Indices1W1M1Y
NIFTY MIDCAP150 3% 12.4% 14.5%
NIFTY MIDCAP150 QUALITY 50 2.9% 12.1% 5.2%
NIFTY LARGE MIDCAP 250 2.8% 12.5% 12.6%
NIFTY MID SMALL400 2.7% 11.4% 11.5%
NIFTY 500 2.6% 12.2% 10.8%

You may also like the below Video Courses


FAQ about AJANTA PHARMA


Is AJANTA PHARMA good for long term investment?

As on Aug 18,2022, the Fundamentals of AJANTA PHARMA look Strong and hence it may be good for long term investment! See Financial Performance of AJANTA PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AJANTA PHARMA UnderValued or OverValued?

As on Aug 18,2022, AJANTA PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AJANTA PHARMA ?

As on Aug 18,2022, the Intrinsic Value of AJANTA PHARMA is Rs. 668.12 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 778.13
Fair Value [Median EV / Sales Model] : Rs. 668.12
Fair Value [Median Price / Sales Model] : Rs. 628.00
Median Fair Value of AJANTA PHARMA : Rs. 668.12

Is AJANTA PHARMA trading at a Premium or Discount?

As on Aug 18,2022, AJANTA PHARMA is trading at a Premium of 88% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].